Dexmedetomidine in PCIA for Caesarean Surgery

Evaluation of adding Dexmedetomidine to the Patient-controlled intravenous analgesia pump (PCIA) on postoperative pain level in caesarean section surgery with spinal anesthesia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230919059468N1

Enrollment

Registered

2024-05-09

Start date

2024-04-06

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after caesarean section - pain after spinal anesthesia.

Interventions

Intervention 1: Intervention group: Routine pain control intravenous pump drugs containing morphine (10mg), Apotel (1g), dexamethasone ampoule (8mg) and one ondansetron ampoule, along with the additio

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Volunteer for caesarean section surgery with spinal anesthesia in anesthesia class ASA1 and ASA 2 Referees of affiliated hospitals of Tehran Azad University of Medical Sciences

Exclusion criteria

Exclusion criteria: The patient's lack of consent to participate in the study History of drug sensitivity to the drugs used Complications of anesthesia and surgery

Design outcomes

Primary

Measure	Time frame
Pain level based on VAS criteria. Timepoint: 6,12 and 18 hours after surgery. Method of measurement: Visual Analogue Scale (VAS).	—

Secondary

Measure	Time frame
The amount of pethidine in people with moderate and severe VAS scores. Timepoint: 6,12 and 18 hours after surgery. Method of measurement: Based on the dosage.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Heidar Darvishi

Islamic Azad University

dr_hdarvishi@yahoo.com+98 21 5534 6552

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026